SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056578
Filing Date
2020-12-09
Accepted
2020-12-09 16:38:52
Documents
15
Period of Report
2020-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20201208.htm   iXBRL 8-K 42798
2 EX-1.1 stro-ex11_34.htm EX-1.1 401861
3 EX-5.1 stro-ex51_92.htm EX-5.1 12259
4 GRAPHIC gib2egvdtyqo000001.jpg GRAPHIC 35429
  Complete submission text file 0001564590-20-056578.txt   718200

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA stro-20201208.xsd EX-101.SCH 5776
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20201208_lab.xml EX-101.LAB 20221
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20201208_pre.xml EX-101.PRE 12084
8 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20201208_htm.xml XML 3679
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 201378259
SIC: 2836 Biological Products, (No Diagnostic Substances)